CERo Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
The closing of the Offering is expected to occur on or about February 7, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offering are expected to be approximately $5 million,
Nuvectis Pharma prices 2.7M shares at $5.00 in underwritten public offering
Nuvectis Pharma (NVCT) announced the pricing of its previously announced underwritten public offering of 2,700,000 shares of its common stock at a
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” public offering of approximately 2.
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
Nuvectis intends to use the net proceeds from this offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital expenditures, costs of operating as a public company and other general corporate purposes.
Volcon, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering
Volcon, Inc. (NASDAQ:VLCN) (the “Company”), the first all-electric, off-road powersports company, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the
Volcon announces public offering of warrants and common shares
Volcon (NASDAQ:VLCN) has commenced a public offering, including common shares (or pre-funded warrants in lieu thereof) and warrants to purchase shares of common stock. The net proceeds from the offering will be used for general corporate and working capital needs.
Volcon, Inc. Announces Launch of Proposed Public Offering
AUSTIN, TX / ACCESS Newswire / February 4, 2025 / Volcon, Inc. (Nasdaq:VLCN) (the "Company"), the first all-electric, off-road
Hosted on MSN3h
Cero Therapeutics prices $5M at-the-market offering
CERo Therapeutics (CERO) announced the pricing of its “reasonable best efforts” public offering with participation from a ...
Houston Chronicle6d
Initial public offerings scheduled to debut next week
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Week of Feb. 3 Titan ...
Nasdaq8d
Akero Therapeutics Announces Pricing of Upsized Public Offering for $350 Million
Akero Therapeutics announced a public offering of over 5.3 million shares at $48 each, aiming for $350 million in proceeds. Akero Therapeutics, Inc. has announced a public offering of 5,333,420 ...
Investopedia10d
When Did Facebook (Meta) Go Public?
Facebook (FB), now Meta Platforms Inc. (META), went public with its initial public offering (IPO) on May 18, 2012. The popular social networking company had one of the largest and most ...
Investing7d
Immunome stock tumbles after public offering pricing
Investing.com -- Immunome, Inc. (NASDAQ:IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnology company ...
Morningstar7d
Immunome Announces Proposed Public Offering of Common Stock
In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public ...